Filing Details

Accession Number:
0000950170-25-021267
Form Type:
13G Filing
Publication Date:
2025-02-13 19:00:00
Filed By:
TCG Crossover GP I, LLC
Company:
Upstream Bio Inc.
Filing Date:
2025-02-14
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
TCG Crossover GP I, LLC 0 2,801,763 5.2%
TCG Crossover Fund I, L.P. 0 2,801,763 5.2%
Chen Yu 0 2,801,763 5.2%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  These securities are held of record by TCG Crossover I (as defined in item 2(a) below). TCG Crossover GP I (as defined in item 2(a) below) is the general partner of TCG Crossover I and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP II and may be deemed to share voting, investment and dispositive power with respect to these securities. The amount beneficially owned by each Reporting Person is determined based on 53,596,601 shares of Common Stock outstanding as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission (the SEC) on November 7, 2024 (the Form 10-Q).


SCHEDULE 13G



Comment for Type of Reporting Person:  These securities are held of record by TCG Crossover I. TCG Crossover GP I is the general partner of TCG Crossover I and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP II and may be deemed to share voting, investment and dispositive power with respect to these securities. The amount beneficially owned by each Reporting Person is determined based on 53,596,601 shares of Common Stock outstanding as reported in the Issuer's Form 10-Q.


SCHEDULE 13G



Comment for Type of Reporting Person:  These securities are held of record by TCG Crossover I. TCG Crossover GP I is the general partner of TCG Crossover I and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP II and may be deemed to share voting, investment and dispositive power with respect to these securities. The amount beneficially owned by each Reporting Person is determined based on 53,596,601 shares of Common Stock outstanding as reported in the Issuer's Form 10-Q.


SCHEDULE 13G


 
TCG Crossover GP I, LLC
 
Signature:/s/ Craig Skaling
Name/Title:Authorized Signatory
Date:02/14/2025
 
TCG Crossover Fund I, L.P.
 
Signature:/s/ Craig Skaling
Name/Title:Authorized Signatory
Date:02/14/2025
 
Chen Yu
 
Signature:/s/ Craig Skaling
Name/Title:By POA as Attorney-in-Fact
Date:02/14/2025